Drug Shortage Report for PMS-AMLODIPINE-ATORVASTATIN
| Report ID | 1726 |
| Drug Identification Number | 02404222 |
| Brand name | PMS-AMLODIPINE-ATORVASTATIN |
| Common or Proper name | Amlodipine-Atorvastatin |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | AMLODIPINE ATORVASTATIN |
| Strength(s) | 5MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C10BX |
| ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2015-07-07 |
| Estimated end date | Unknown |
| Actual end date | 2020-04-01 |
| Shortage status | Resolved |
| Updated date | 2020-04-02 |
| Company comments | Product to be discontinued. It will be relaunched under new DIN |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-04-02 | French | Compare |
| v4 | 2020-04-02 | English | Compare |
| v3 | 2017-03-13 | French | Compare |
| v2 | 2017-03-13 | English | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 5 of 5